跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
拉坦噻吗滴眼液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Latanoprost and Timolol Maleate Eye Drops
Approved
化学药品
Latanoprost and Timolol Maleate Eye Drops
VIATRIS HEALTHCARE
🇨🇳 National Medical Products Administration
Approval Date
Mar 21, 2022
Approval ID
8FWSEbZ1VzB
Company
VIATRIS HEALTHCARE
Type
化学药品
Approval Details
Approval Id
8FWSEbZ1VzB
Approval Number
国药准字HJ20171093
Generic Name
拉坦噻吗滴眼液
Generic Name En
Latanoprost and Timolol Maleate Eye Drops
Drug Type
化学药品
Dosage Form
眼用制剂
Strength
2.5ml:拉坦前列素125μg与马来酸噻吗洛尔12.5mg(按C₁₃H₂₄N₄O₃S计)
Reg Date
2022-03-21
Expired Date
2027-03-20
Company Name
VIATRIS HEALTHCARE
Production Company Name
Pfizer Manufacturing Belgium
Company Detail Path
/organization/viatris-healthcare
Production Company Detail Path
/organization/pfizer-manufacturing-belgium
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 21, 2022
Approval ID
8FWSEbZ1VzB
Type
化学药品
Back to NMPA Approvals